Evidence map›Paper›PMID 40430373›Full record

ArticleMolecules (Basel, Switzerland)2025

Design and Evaluation of a Crosslinked Chitosan-Based Scaffold Containing Hyaluronic Acid for Articular Cartilage Reconstruction.

Salim Hamidi, Mickael Maton, Feng Hildebrand, Valérie Gaucher, Cédric Bossard, Frédéric Cazaux, Jean Noel Staelens, Nicolas Blanchemain, Bernard Martel

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Salim HamidiUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.
Mickael MatonUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.
Feng HildebrandUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.
Valérie GaucherUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0002-1862-5004
Cédric BossardUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.
Frédéric CazauxUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0001-8861-9905
Jean Noel StaelensUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.ORCID 0000-0002-7092-7165
Nicolas BlanchemainUniv. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France.
Bernard MartelUniv. Lille, CNRS, INRAE, Centrale Lille, UMR 8207-UMET-Unité Matériaux et Transformations, F-59000 Lille, France.

Funding

Ministère de l'Enseignement Supérieur et de la Recherche xx
6 · The paper itself

Abstract

Polymeric scaffolds are promising in tissue engineering due to their structural similarity to extracellular matrix components. This study aimed to design freeze-dried hydrogels based on chitosan (CHT) and hyaluronic acid (HA). Chitosan-based gels were crosslinked with oxidized maltodextrin (MDo) before the freeze-drying step, resulting in spongy porous scaffolds. Based on the state-of-the-art, our hypothesis was that crosslinking would increase scaffold stiffness and delay the degradation of the CHT:HA resorbable scaffolds swelled in a hydrated physiological environment. The physicochemical and mechanical properties of crosslinked CHT- and CHT:HA-based scaffolds were analyzed. Hygroscopic and swelling behavior were assessed using dynamic vapor sorption analysis and batch studies. Degradation was evaluated under different conditions, including in phosphate-buffered saline (PBS), PBS with lysozyme, and lactic acid solutions, to investigate scaffold resistance against enzymatic and acidic degradation. The porosity of the spongy materials was characterized using scanning electron microscopy, while dynamic mechanical analysis provided information on the mechanical properties. Crosslinked scaffolds showed reduced swelling, slower degradation rates, and increased stiffness, confirming MDo as an effective crosslinking agent. Scaffolds loaded with ciprofloxacin (CFX) demonstrated their ability to deliver therapeutic agents, as the CFX loading capacity was promoted by CHT-CFX interactions. Microbiologic investigation confirmed the results. Finally, cytotoxicity tests displayed no toxicity. In conclusion, MDo-crosslinked CHT and CHT:HA scaffolds exhibit enhanced stability, functionality, and mechanical performance, making them promising for cartilage tissue engineering.

Indexed as

Cartilage, ArticularChitosanHyaluronic AcidTissue ScaffoldsAnimalsBiocompatible MaterialsCross-Linking ReagentsHumansHydrogelsPorosityTissue EngineeringBiocompatible MaterialsChitosanCross-Linking ReagentsHyaluronic AcidHydrogelscartilage tissue engineeringchitosanciprofloxacincrosslinking hydrogelsdrug releaseenzymatic degradationhyaluronic acidmechanical stabilitypolymeric scaffoldsporous morphology

Identifiers

PMID40430373
PMCPMC12113991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.